Business Description
Valeo Pharma Inc
NAICS : 325412
SIC : 3741
ISIN : CA91915B1085
Share Class Description:
FRA:VP2: Ordinary SharesCompare
Compare
Traded in other countries / regions
VPH.CanadaVPHIF.USAVP2.Germany IPO Date
2020-08-11Description
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | -1.17 | |||||
| Debt-to-Equity | -1.4 | |||||
| Debt-to-EBITDA | -5.76 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -3.58 | |||||
| Beneish M-Score | -5.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 69.3 | |||||
| 3-Year EBITDA Growth Rate | -26.6 | |||||
| 3-Year EPS without NRI Growth Rate | -58.4 | |||||
| 3-Year FCF Growth Rate | -28.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 39.81 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.21 | |||||
| 9-Day RSI | 47.75 | |||||
| 14-Day RSI | 47.38 | |||||
| 6-1 Month Momentum % | -6.19 | |||||
| 12-1 Month Momentum % | -63.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.49 | |||||
| Quick Ratio | 0.3 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 104.06 | |||||
| Days Sales Outstanding | 35.75 | |||||
| Days Payable | 61.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.5 | |||||
| Shareholder Yield % | -87.14 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 21.38 | |||||
| Operating Margin % | -33.58 | |||||
| Net Margin % | -52.37 | |||||
| FCF Margin % | -15.6 | |||||
| ROA % | -63.68 | |||||
| ROIC % | -59.91 | |||||
| ROC (Joel Greenblatt) % | -207.28 | |||||
| ROCE % | -63.82 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.25 | |||||
| EV-to-EBIT | -5.04 | |||||
| EV-to-EBITDA | -6.22 | |||||
| EV-to-Revenue | 1.31 | |||||
| EV-to-Forward-Revenue | 1.14 | |||||
| EV-to-FCF | -8.51 | |||||
| Earnings Yield (Greenblatt) % | -19.85 | |||||
| FCF Yield % | -56.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valeo Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 37.118 | ||
| EPS (TTM) (€) | -0.226 | ||
| Beta | 1.75 | ||
| Volatility % | 115.3 | ||
| 14-Day RSI | 47.38 | ||
| 14-Day ATR (€) | 0.008795 | ||
| 20-Day SMA (€) | 0.091575 | ||
| 12-1 Month Momentum % | -63.7 | ||
| 52-Week Range (€) | 0.058 - 0.324 | ||
| Shares Outstanding (Mil) | 98.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valeo Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valeo Pharma Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Valeo Pharma Inc Frequently Asked Questions
What is Valeo Pharma Inc(FRA:VP2)'s stock price today?
The current price of FRA:VP2 is €0.09. The 52 week high of FRA:VP2 is €0.32 and 52 week low is €0.06.
When is next earnings date of Valeo Pharma Inc(FRA:VP2)?
The next earnings date of Valeo Pharma Inc(FRA:VP2) is .
Does Valeo Pharma Inc(FRA:VP2) pay dividends? If so, how much?
Valeo Pharma Inc(FRA:VP2) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers